PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT

Brand Owner (click to sort) Address Description
STAT-C.V. PORTON DIAGNOSTICS, INC. 26709 W. AGOURA ROAD CALABASAS CA 91302 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;
STAT-CHOL PORTON DIAGNOSTICS, INC. 26709 W. AGOURA ROAD CALABASAS CA 91302 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;
STAT-COMBI PORTON DIAGNOSTICS, INC. 26709 W. AGOURA ROAD CALABASAS CA 91302 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;
STAT-GLU INTERNATIONAL CARDIOVASCULAR MEDICINE, INC. SUITE 211 18345 VENTURA BOULEVARD TARZANA CA 91356 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;STATUS GLUCOSE;
STAT-GLUCOSE PORTON DIAGNOSTICS, INC. 26709 W. AGOURA ROAD CALABASAS CA 91302 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;STATUS GLUCOSE;
STAT-HDL PORTON DIAGNOSTICS, INC. 26709 W. AGOURA ROAD CALABASAS CA 91302 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;STATUS-HDL;
STAT-HEMO-CRIT PORTON DIAGNOSTICS, INC. 26709 W. AGOURA ROAD CALABASAS CA 91302 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;
STAT-LDL PORTON DIAGNOSTICS, INC. 26709 W. AGOURA ROAD CALABASAS CA 91302 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;STATUS-LDL;
STAT-LIT PORTON DIAGNOSTICS, INC. 26709 W. AGOURA ROAD CALABASAS CA 91302 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;
STAT-LITHIUM INTERNATIONAL CARDIOVASCULAR MEDICINE, INC. SUITE 211 18345 VENTURA BOULEVARD TARZANA CA 91356 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;
STAT-PSYCH PORTON DIAGNOSTICS, INC. 26709 W. AGOURA ROAD CALABASAS CA 91302 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;
STAT-SCREEN INTERNATIONAL CARDIOVASCULAR MEDICINE, INC. SUITE 211 18345 VENTURA BOULEVARD TARZANA CA 91356 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;
STAT-TRIG PORTON DIAGNOSTICS, INC. 26709 W. AGOURA ROAD CALABASAS CA 91302 PORTABLE BLOOD CHEMISTRY DIAGNOSTIC UNIT;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to contrast agents for diagnostic imaging with prolonged blood retention. In particular, this invention relates to novel compounds that are characterized by an image enhancing moiety (IEM); a protein plasma binding moiety (PPBM); and a blood half-life extending moiety (BHEM). This invention also relates to pharmaceutical compositions comprising these compounds and to methods of using the compounds and compositions for blood half-life extension and contrast enhancement of diagnostic imaging.